Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-03 21:46 | 2026-04-01 | ARQT | Arcutis Biotherapeutics, Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $23.88 | 10,000 | $238,801 | 39,744 | -20.1% |
| 2026-03-05 00:16 | 2026-03-02 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $25.65 | 10,000 | $256,518 | 49,744 | -16.7% |
| 2026-02-05 03:23 | 2026-02-02 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $25.05 | 10,000 | $250,483 | 59,744 | -14.3% |
| 2026-01-07 01:31 | 2026-01-02 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $28.96 | 10,000 | $289,606 | 69,744 | -12.5% |
| 2025-12-04 01:23 | 2025-12-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $30.21 | 10,000 | $302,133 | 79,744 | -11.1% |
| 2025-11-06 02:24 | 2025-11-03 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $25.27 | 10,000 | $252,669 | 89,744 | -10.0% |
| 2025-10-04 00:01 | 2025-10-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $18.92 | 10,000 | $189,227 | 99,744 | -9.1% |
| 2025-09-05 01:41 | 2025-09-02 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $15.64 | 10,000 | $156,383 | 100,206 | -9.1% |
| 2025-08-06 01:28 | 2025-08-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $14.30 | 10,000 | $142,982 | 100,206 | -9.1% |
| 2025-07-02 23:25 | 2025-07-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $13.84 | 9,208 | $127,430 | 100,206 | -8.4% |
| 2025-06-20 23:32 | 2025-06-18 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $13.37 | 10,139 | $135,574 | 109,414 | -8.5% |
| 2025-05-05 23:49 | 2025-05-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $14.64 | 10,000 | $146,357 | 111,944 | -8.2% |
| 2025-04-03 23:21 | 2025-04-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $15.12 | 10,000 | $151,236 | 121,944 | -7.6% |
| 2025-03-05 03:43 | 2025-03-03 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $13.00 | 10,000 | $130,048 | 131,944 | -7.0% |
| 2025-02-05 04:00 | 2025-02-03 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $12.71 | 10,000 | $127,100 | 141,944 | -6.6% |
| 2025-01-07 00:08 | 2025-01-02 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $14.67 | 10,000 | $146,714 | 151,944 | -6.2% |
| 2024-12-04 00:16 | 2024-12-02 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $12.51 | 10,000 | $125,133 | 161,944 | -5.8% |
| 2024-11-06 00:46 | 2024-11-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $8.65 | 10,000 | $86,541 | 171,944 | -5.5% |
| 2024-10-03 23:55 | 2024-10-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $9.26 | 10,000 | $92,616 | 181,944 | -5.2% |
| 2024-09-06 00:56 | 2024-09-03 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $10.77 | 10,000 | $107,695 | 191,944 | -5.0% |
| 2024-08-05 23:37 | 2024-08-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $9.87 | 10,000 | $98,696 | 176,953 | -5.3% |
| 2024-07-03 02:13 | 2024-07-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $9.31 | 10,000 | $93,141 | 180,339 | -5.3% |
| 2024-06-06 23:15 | 2024-06-04 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $8.01 | 10,000 | $80,092 | 170,200 | -5.5% |
| 2023-04-19 02:00 | 2023-04-17 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $13.97 | 8,500 | $118,728 | 165,825 | -4.9% |
| 2023-04-10 23:13 | 2023-04-06 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $12.01 | 8,500 | $102,085 | 165,825 | -4.9% |
| 2023-02-21 15:20 | 2023-02-15 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $16.98 | 8,500 | $144,352 | 165,825 | -4.9% |
| 2023-01-19 04:18 | 2023-01-17 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $13.72 | 8,500 | $116,655 | 165,825 | -4.9% |
| 2022-11-18 00:29 | 2022-11-15 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $20.01 | 3,403 | $68,103 | 165,825 | -2.0% |
| 2022-10-06 23:26 | 2022-10-04 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $20.29 | 6,000 | $121,766 | 168,208 | -3.4% |
| 2022-08-18 00:06 | 2022-08-15 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $24.80 | 6,000 | $148,789 | 174,208 | -3.3% |
| 2022-07-19 01:53 | 2022-07-18 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $24.40 | 6,000 | $146,374 | 180,208 | -3.2% |
| 2022-06-02 23:48 | 2022-06-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $20.62 | 2,500 | $51,539 | 181,896 | -1.4% |
| 2022-05-04 00:14 | 2022-05-02 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $20.44 | 2,500 | $51,112 | 181,896 | -1.4% |
| 2022-04-01 23:55 | 2022-04-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $20.02 | 7,500 | $150,184 | 181,896 | -4.0% |
| 2022-01-06 01:19 | 2022-01-03 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $21.21 | 2,500 | $53,030 | 181,896 | -1.4% |
| 2021-12-24 05:46 | 2021-12-23 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $20.16 | 2,500 | $50,396 | 181,896 | -1.4% |
| 2021-11-04 00:16 | 2021-11-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $21.81 | 2,500 | $54,524 | 181,896 | -1.4% |
| 2021-10-05 21:11 | 2021-10-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $23.87 | 2,500 | $59,680 | 181,896 | -1.4% |
| 2021-09-04 00:07 | 2021-09-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $20.80 | 5,000 | $103,987 | 181,896 | -2.7% |
| 2021-07-07 02:14 | 2021-07-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $26.13 | 2,200 | $57,476 | 181,896 | -1.2% |
| 2021-06-03 23:37 | 2021-06-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $27.09 | 2,200 | $59,603 | 212,553 | -1.0% |
| 2021-05-05 21:05 | 2021-05-03 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $34.79 | 2,200 | $76,547 | 210,941 | -1.0% |
| 2021-04-06 00:33 | 2021-04-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $29.49 | 2,200 | $64,880 | 208,286 | -1.0% |
| 2021-03-04 00:45 | 2021-03-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $34.37 | 2,200 | $75,610 | 205,633 | -1.1% |
| 2021-02-03 19:24 | 2021-02-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $34.35 | 2,200 | $75,572 | 183,118 | -1.2% |
| 2021-01-06 21:16 | 2021-01-04 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $27.82 | 2,200 | $61,215 | 181,896 | -1.2% |
| 2020-12-04 03:40 | 2020-12-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $25.98 | 2,200 | $57,154 | 179,844 | -1.2% |
| 2020-11-05 00:33 | 2020-11-02 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $18.27 | 2,200 | $40,186 | 178,622 | -1.2% |
| 2020-10-06 04:13 | 2020-10-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $27.65 | 2,200 | $60,829 | 177,400 | -1.2% |
| 2020-09-02 18:48 | 2020-09-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $24.38 | 2,200 | $53,643 | 176,178 | -1.2% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.